Australia markets open in 3 hours 26 minutes

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
43.46+0.28 (+0.65%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 8.77B
Enterprise value 7.81B
Trailing P/E 29.56
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.94
Price/book (mrq)4.36
Enterprise value/revenue 9.18
Enterprise value/EBITDA 20.03

Trading information

Stock price history

Beta (5Y monthly) 0.37
52-week change 328.81%
S&P500 52-week change 316.57%
52-week high 358.66
52-week low 332.15
50-day moving average 341.02
200-day moving average 344.01

Share statistics

Avg vol (3-month) 31.86M
Avg vol (10-day) 31.21M
Shares outstanding 5201.83M
Implied shares outstanding 6201.83M
Float 8112.18M
% held by insiders 143.33%
% held by institutions 110.47%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.44
Forward annual dividend yield 41.01%
Trailing annual dividend rate 30.44
Trailing annual dividend yield 31.02%
5-year average dividend yield 40.83
Payout ratio 429.93%
Dividend date 3N/A
Ex-dividend date 404 July 2023
Last split factor 21.3:1
Last split date 326 May 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 June 2023

Profitability

Profit margin 33.61%
Operating margin (ttm)27.15%

Management effectiveness

Return on assets (ttm)5.69%
Return on equity (ttm)15.62%

Income statement

Revenue (ttm)851.03M
Revenue per share (ttm)4.37
Quarterly revenue growth (yoy)13.40%
Gross profit (ttm)699.86M
EBITDA 293.48M
Net income avi to common (ttm)286M
Diluted EPS (ttm)1.47
Quarterly earnings growth (yoy)20.00%

Balance sheet

Total cash (mrq)1.7B
Total cash per share (mrq)8.56
Total debt (mrq)733.21M
Total debt/equity (mrq)36.49%
Current ratio (mrq)3.26
Book value per share (mrq)10.14

Cash flow statement

Operating cash flow (ttm)317.58M
Levered free cash flow (ttm)13.18M